In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...
Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.
The majority of other information websites display prices from a single source, most of the time from one retail broker-dealer. At FXStreet, traders get interbank rates coming from a systematic ...
Replay the call for the latest insights. Updated 15m ago · Powered by Yahoo Scout ...
Replay the call for the latest insights.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results